Peptide hydrogels as slow-release formulations of protein therapeutics: case study of asparaginase-loaded hydrogels

Biomater. Sci., 2025, Advance Article
DOI: 10.1039/D5BM00138B, Paper

Open Access

&nbsp This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Hue Vu, Evelien Peeters, Kenneth Hofkens, Katrien Vandemeulebroecke, Sara T'Sas, Charlotte Martin, Steven Ballet, Richard Hoogenboom, Steven Goossens, Tim Lammens, Maaike Van Trimpont, Annemieke Madder
An injectable peptide hydrogel was used for the sustained release of Erwinase®, an FDA-approved therapeutic enzyme against acute lymphoblastic leukemia.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry